J. Goldman & Co’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
100,777
-17,817
| -15% | -$249K | 0.03% | 232 |
|
|
2025
Q1 | $1.6M | Sell |
118,594
-60,902
| -34% | -$821K | 0.04% | 211 |
|
|
2024
Q4 | $3.44M | Buy |
+179,496
| New | +$3.44M | 0.09% | 172 |
|
|
2024
Q3 | – | Sell |
-74,985
| Closed | -$976K | – | 489 |
|
|
2024
Q2 | $976K | Buy |
74,985
+30,721
| +69% | +$400K | 0.03% | 210 |
|
|
2024
Q1 | $775K | Buy |
+44,264
| New | +$775K | 0.03% | 197 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 364 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 383 |
|